Trammell Crow Company has announced that it signed a 35,021-square-foot lease for MonoSol to locate a new innovation and technical center within its Fulton Labs campus in Chicago’s Fulton Market neighborhood. MonoSol, a sustainable material science company headquartered in Northwest Indiana, is a division of Tokyo-based Kuraray Group and is best known for its water-soluble, biodegradable films used to make laundry and dishwashing detergent packets for many of the world's biggest household brands. When open in mid-2024, MonoSol’s innovation center will occupy the last full floor at 1375 West Fulton, bringing the 300,000-square-foot life science building to approximately 98 percent leased.

1375 W. FultonTrammell Crow Company

MonoSol will house its strategic innovation, research and design capabilities for its water-soluble film and material science technologies at 1375 W. Fulton. The company follows in the footsteps of hundreds of other major corporations standing up operations in Chicago recently. 

“The Fulton Labs campus offers MonoSol’s innovators and customers the advanced lab and collaboration space, modern amenities and accessibility we require to build on our track record of developing new materials that make everyday life safer, simpler and more sustainable,” said MonoSol’s President, Christian Hermanns. “The campus and surrounding neighborhood create the vibrant and creative atmosphere that mirrors our own passion, energy and forward-thinking spirit.”

1375 W. FultonTrammell Crow Company

Trammell Crow Company’s Fulton Labs campus, totaling 725,000 square feet across two buildings, is part of the firm’s 1.2-million-square-foot life science portfolio in Chicagoland, which also includes the under-construction Evanston Labs (175,000 square feet) and Hyde Park Labs (302,000 square feet), both slated for delivery in 2024.

Additional Fulton Labs tenants at 1375 include Belay Diagnostics, Charles River Laboratories, Dimension Inx, Celadyne Technologies, Portal Innovations, Xeris Pharmaceuticals, Vanqua Bio, and Talis Biomedical.